Sex-Related Differences in the Long-Term Outcomes of Patients with Femoropopliteal Arterial Disease Treated with the IN.PACT Drug-Coated Balloon in the IN.PACT SFA Randomized Controlled Trial: A Post Hoc Analysis
Open Access
- 1 September 2020
- journal article
- conference paper
- Published by Elsevier in Journal of Vascular and Interventional Radiology
- Vol. 31 (9) , 1410-1418.e10
Abstract
No abstract availableKeywords
Funding Information
- 480 Biomedical
- Bard Peripheral Vascular
- Veryan Medical
- Biotronik
- Cook Medical
- W.L. Gore & Associates
- Medtronic
- Philips Healthcare
- Terumo Medical Corporation
- TriReme Medical
- Shockwave Medical
- MedAlliance
- Intact Vascular
This publication has 20 references indexed in Scilit:
- Drug-Coated Balloons for Complex Femoropopliteal LesionsJACC: Cardiovascular Interventions, 2016
- Durability of Treatment Effect Using a Drug-Coated Balloon for Femoropopliteal LesionsJACC, 2015
- Trial of a Paclitaxel-Coated Balloon for Femoropopliteal Artery DiseaseNew England Journal of Medicine, 2015
- Drug-Coated Balloon Versus Standard Percutaneous Transluminal Angioplasty for the Treatment of Superficial Femoral and Popliteal Peripheral Artery DiseaseCirculation, 2015
- Angioplasty of Femoral-Popliteal Arteries With Drug-Coated BalloonsJACC: Cardiovascular Interventions, 2015
- Comparison of global estimates of prevalence and risk factors for peripheral artery disease in 2000 and 2010: a systematic review and analysisThe Lancet, 2013
- Paclitaxel-Coated Balloons Reduce Restenosis After Femoro-Popliteal AngioplastyCirculation: Cardiovascular Interventions, 2012
- A Call to Action: Women and Peripheral Artery DiseaseCirculation, 2012
- Lessons learned from the analysis of gender effect on risk factors and procedural outcomes of lower extremity arterial diseaseJournal of Vascular Surgery, 2010
- Local Delivery of Paclitaxel to Inhibit Restenosis during Angioplasty of the LegNew England Journal of Medicine, 2008